Multicenter, Randomized, Double-blind, Placebo / Positive Control Evaluation of the First Safety, Pharmacokinetic and Pharmacodynamic Phase I Clinical Trial of Rabies Monomab CBB 1 in Healthy People
Latest Information Update: 08 May 2023
At a glance
- Drugs Monoclonal-antibody-CBB-1-injection (Primary) ; Rabies immune globulin (Primary)
- Indications Rabies
- Focus Adverse reactions
- Sponsors Changchun BCHT Biotechnology
Most Recent Events
- 08 May 2023 New trial record